Streetbeat News

Products Services

TNON

Tenon Medical has received a Notice of Allowance for a U.S. patent on its systems and methods for stabilizing sacroiliac joints. This development could enhance its product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 2:33 pm

BVNKF

BVNRY

The Democratic Republic of Congo received its first batch of mpox vaccines, nearly two years after declaring an epidemic. The vaccines, MVA-BN, are produced by Bavarian Nordic A/S and are the only approved mpox vaccines in several regions. The delay in vaccine distribution is attributed to regulatory and logistical challenges.

Portfolio Pulse from Vandana Singh

September 06, 2024 | 2:03 pm

TAK

TEVA

VTRS

The DEA has authorized a 24% increase in production limits for Takeda's Vyvanse to address the ADHD medication shortage in the U.S. and meet international demand. This move follows the FDA's request and aims to stabilize supply amid rising demand and manufacturing delays.

Portfolio Pulse from Vandana Singh

September 06, 2024 | 1:46 pm

PFE

VOR

Vor Biopharma Inc. (NASDAQ:VOR) announced promising clinical data from its Phase 1/2 VBP101 study for treating acute myeloid leukemia (AML) with trem-cel and Pfizer's Mylotarg. The data showed reliable engraftment and early patient benefits, leading to a 28.5% increase in VOR's stock price. Vor Bio plans to discuss a pivotal trial with the FDA and has announced a new preclinical asset, VADC45.

Portfolio Pulse from Vandana Singh

September 06, 2024 | 1:35 pm

DAVA

EPAM

GLOB

JPMorgan has identified Endava Plc (NYSE:DAVA) as a 'top pick' in the IT services sector, projecting over 50% upside due to its strong position in digital transformation. Despite macroeconomic concerns, Endava's growth prospects in high-demand sectors like payments and telecoms make it a promising investment.

Portfolio Pulse from Surbhi Jain

September 06, 2024 | 1:28 pm

LGND

TVTX

Travere Therapeutics has received full FDA approval for FILSPARI, a treatment for IgA nephropathy (IgAN), based on the PROTECT Study. Ligand Pharmaceuticals is entitled to a 9% royalty on worldwide net sales of FILSPARI.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 1:23 pm

BSFC

Blue Star Foods has reiterated its 2024 forecast of at least 65% revenue growth, driven by a strong business pipeline, new product roll-outs, and technological advancements in its operations.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 1:01 pm

FUBO

Fubo has introduced a new proprietary CTV ad format aimed at enhancing branded video content. This development expands interactive ad opportunities on Fubo's platform, potentially increasing its advertising revenue.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 1:01 pm

CORZ

Core Scientific has announced a 30-day extension for CoreWeave's option to contract 118 megawatts of infrastructure for high-performance computing (HPC). This extension could impact Core Scientific's operations and future revenue streams.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:48 pm

CSGP

DELL

JNJ

PYPL

On CNBC's 'Halftime Report Final Trades,' analysts discussed Dell, CoStar, Johnson & Johnson, and PayPal. Dell and CoStar reported strong earnings, while Johnson & Johnson increased its settlement offer for talc-related claims. PayPal is integrating with Apple's mobile wallet.

Portfolio Pulse from Avi Kapoor

September 06, 2024 | 12:47 pm